Email this article to a friend
On the way to specifically targeting minimal residual disease?
-
Correspondence: Gerhard Gebauer gerhard.gebauer@med.uni-heidelberg.de
Breast Cancer Research 2008, 10:112 doi:10.1186/bcr2148